Egr1 is rapidly and transiently induced by estrogen and bisphenol A via activation of nuclear estrogen receptor-dependent ERK1/2 pathway in the uterus

Coordinate actions of ovarian estrogen (E-2) and progesterone (P-4) via their own receptors are critical for establishing uterine receptivity for embryo implantation in the uterus. E-2 regulates expression of an array of genes to mediate its major actions on heterogeneous uterine cell types. Here we have investigated regulatory mechanism(s) of E-2 and bisphenol A (BPA), an endocrine disruptor with potent estrogenic activity on expression of early growth response 1 (Egrl), a zinc finger transcription factor that regulates cell growth, differentiation and apoptosis in the uterus. Egrl was rapidly and transiently induced by E-2 and BPA mainly in stromal cells via nuclear estrogen receptor (ER)-ERK1/2 pathway. ICI 182,780, an ER antagonist, effectively inhibited their actions on EGR1 expression following ERK1/2 phosphorylation. Administration of pharmacological inhibitors for ERK1/2, but not AKT significantly blocked EGR1 expression induced by E-2 and BPA. P-4 effectively dampened action(s) of E-2 and BPA on Egrl expression via nuclear progesterone receptor. Its antagonistic effects were partially interfered with RU486 pretreatment. Interestingly, EGR1 is specifically induced in stromal cells surrounding implanting blastocyst. Collectively, our results show that through nuclear ER-dependent ERK1/2 phosphorylation, not only E-2 but also endocrine disruptors with estrogenic activity such as BPA rapidly and transiently induce Egrl which may be important for embryo implantation and decidualization in mouse uterus. (C) 2014 Elsevier Inc. All rights reserved.